Corestreet Logo

Regulus Therapeutics Inc (RGLS) Insider Trading

Total insider buys:
  • $20,284,933.82
Total insider sells:
  • $44,423,164.07
Most recent insider trade:
  • June 3, 2025
Most active insider trader:
  • Isis Pharmaceuticals Inc
Trader NameDateTitleAmountPriceTypeTotal Value
March 7, 2017Director250,000$1.15Buy$287,500.00
March 3, 2016COO10,000$7.19Buy$71,900.00
Feb. 23, 2016Major Shareholder1,000,000$7.18Sell$7,180,000.00
July 21, 2015Director100,000$10.17Buy$1,017,000.00
July 20, 2015Director38,765$10.13Buy$392,689.45
July 17, 2015Major Shareholder343,133$10.60Sell$3,637,209.80
April 21, 2015CEO200,000$17.15Sell$3,430,000.00
April 13, 2015Director20,000$17.66Sell$353,200.00
March 5, 2015CEO89,230$20.26Sell$1,807,799.80
Feb. 2, 2015CEO5,700$19.61Sell$111,777.00
Jan. 29, 2015CEO145,000$18.06Sell$2,618,700.00
Jan. 28, 2015Insider80,000$18.05Sell$1,444,000.00
Nov. 28, 2014Insider2,500$19.30Sell$48,250.00
Nov. 3, 2014Major Shareholder1,279,411$15.94Sell$20,393,811.34
Oct. 24, 2014Major Shareholder113,084$14.02Sell$1,585,437.68
Oct. 22, 2014Insider3,300$14.44Sell$47,652.00
Oct. 10, 2014Major Shareholder2,000$6.41Sell$12,820.00
Oct. 10, 2014Director10,050$6.56Sell$65,928.00
Oct. 9, 2014Director4,750$6.58Sell$31,255.00
Oct. 8, 2014Director3,300$6.63Sell$21,879.00
Oct. 3, 2014Major Shareholder10,300$6.74Sell$69,422.00
Oct. 3, 2014Director3,300$6.88Sell$22,704.00
Oct. 2, 2014Director3,750$6.64Sell$24,900.00
Oct. 1, 2014Director3,250$6.71Sell$21,807.50
Sept. 30, 2014CEO2,300$7.02Sell$16,146.00
Sept. 26, 2014Director8,750$7.13Sell$62,387.50
Sept. 26, 2014Major Shareholder2,500$7.04Sell$17,600.00
Sept. 25, 2014Major Shareholder2,500$7.12Sell$17,800.00
Sept. 24, 2014Major Shareholder3,750$7.19Sell$26,962.50
Sept. 19, 2014Director4,100$7.22Sell$29,602.00
Sept. 19, 2014Major Shareholder7,700$7.31Sell$56,287.00
Sept. 18, 2014Director1,500$7.40Sell$11,100.00
Sept. 17, 2014Director2,100$7.43Sell$15,603.00
Sept. 12, 2014Major Shareholder8,900$7.85Sell$69,865.00
Sept. 12, 2014Director3,500$7.96Sell$27,860.00
Sept. 12, 2014Insider4,200$8.01Sell$33,642.00
Sept. 11, 2014Director3,400$7.83Sell$26,622.00
Sept. 10, 2014Director2,000$7.70Sell$15,400.00
Sept. 5, 2014Director10,050$7.07Sell$71,053.50
Aug. 29, 2014Director1,500$6.84Sell$10,260.00
Aug. 28, 2014Director2,000$6.96Sell$13,920.00
Aug. 28, 2014CEO3,505$7.06Sell$24,745.30
Aug. 27, 2014Director1,500$7.21Sell$10,815.00
Aug. 22, 2014Major Shareholder5,250$6.75Sell$35,437.50
Aug. 21, 2014Major Shareholder2,500$6.89Sell$17,225.00
Aug. 20, 2014Major Shareholder3,000$7.14Sell$21,420.00
Aug. 15, 2014Major Shareholder1,450$6.98Sell$10,121.00
Aug. 14, 2014Major Shareholder1,750$7.04Sell$12,320.00
Aug. 13, 2014Major Shareholder2,250$7.02Sell$15,795.00
Aug. 8, 2014Director1,850$6.80Sell$12,580.00
First«2 of 3»Last

  • Insiders are both buying and selling Regulus Therapeutics Inc stock.

  • The insider traders at Regulus Therapeutics Inc are: Isis Pharmaceuticals Inc, Joseph P Hagan, Alnylam Pharmaceuticals, Inc., Christopher Ray Aker, Kleanthis G Xanthopoulos, William H Rastetter, Daniel R Chevallard, Neil W Gibson, Neil Gibson, Stelios Papadopoulos, Preston Klassen, Kathryn J Collier, Crispina Calsada, Peter J Barris, Sanofi, Stanley T Crooke, David Baltimore, Denis Drygin, Kleanthis Xanthopoulos, Bruce L A Carter, Pascale Witz, and Paul Edward Walker

  • The most active insider trader at Regulus Therapeutics Inc is Isis Pharmaceuticals Inc with 34 trades.

  • Isis Pharmaceuticals Inc has sold the most Regulus Therapeutics Inc stock with a total value of $28,417,089.94.

  • Sanofi has bought the most Regulus Therapeutics Inc stock with a total value of $19,999,985.20.

  • The most recent insider trade for Regulus Therapeutics Inc was on June 3, 2025.

  • The single biggest insider buy for Regulus Therapeutics Inc was from Sanofi with a total value of $9,999,992.60 on Feb. 4, 2014.

  • The single biggest insider sell for Regulus Therapeutics Inc was from Isis Pharmaceuticals Inc with a total value of $20,393,811.34 on Nov. 3, 2014.